目的 对天津中医药大学第一附属医院2019-2020年活血类中药注射剂使用合理性进行分析总结,为临床合理用药提供参考。方法 通过医院信息系统和Excel软件统计分析2019年1月-2020年12月活血类中药注射剂的使用情况。结果 2020年天津中医药大学第一附属医院活血类中药注射剂应用较2019年整体下降20.68%,但占中成药总体金额的比例基本持平;活血类中药注射剂2019年和2020年销售金额与使用频度最高的品种固定,均为注射用血栓通(冻干);2020年活血类中药注射剂的平均日费用整体下降,并且同步性更加合理;活血类中药注射剂使用受到了新冠疫情的一定冲击,但医疗政策对活血类中药注射剂应用的影响更大。结论 活血类中药注射剂是医院用药的重要组成部分,应用相对合理,继续提高合理用药水平,能够保证其在临床中发挥更大的作用。

Objective To analyze and summarize the use and rationality of blood-activating TCM injections in First Teaching Hospital of Tianjin University of Traditional Chinese Medicine from 2019 to 2020, so as to provide reference for rational drug use in clinic. Methods The hospital information system and Excel software were used to analyze the use of TCM injections for promoting blood circulation from January 2019 to December 2020. Results In 2020 the application of blood-activating Chinese medicine injections in our hospital decreased by 20.68% compared with 2019, but the proportion of total Chinese patent medicine was basically the same. Xueshuantong (freeze-dried) for injection is the blood activating traditional Chinese medicine injection with the highest sales amount and use frequency in 2019 and 2020. The average daily cost of blood-activating TCM injections in 2020 decreased as a whole, and the synchronization was more reasonable. Although the use of blood-activating TCM injections has been affected by COVID-19, medical policies have a greater impact on the application of traditional Chinese medicine injections. Conclusion Blood-activating traditional Chinese medicine injection is an important part of hospital medication, and its application is relatively reasonable, and continue to improve the level of rational drug use, so that it can play a greater role in clinical practice.

R286